Skip to main content

Table 1 Descriptive data of PLWHA on ART at the regional hospital of Sokodé, Togo

From: Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS at the regional hospital of Sokodé, Togo

Patients characteristics N (%) Measurement of adherence Global adherencen (%) p-value
Self-report Appointment pills count
n (%) n (%) n (%)
Sex   * ° °   0.283
Male 90 (30.9) 73 (81.1) 78 (86.7) 74 (82.2) 74 (82.2)  
Female 201 (69.1) 139 (69.2) 172 (85.6) 144 (71.6) 154 (76.6)  
Age   ° ° *   0.168
Less than 25 years 26 (8.9) 21 (80.8) 25 (96.2) 17 (65.4] 21 (80.8)  
25-35 years 109 (37.5) 74 (67.9) 91 (83.5) 75 (68.8) 79 (72.5)  
More than 35 years 156 (53.6) 117 (75.0) 134 (85.9) 126 (80.8) 128 (82.1)  
Marital status   ° ° °   0.330
Single/widower/divorced 96 (33.0) 64 (66.7) 84 (87.5) 68 (70.8) 72 (75.0)  
Married/in couple 195 (67.0) 148 (75.9) 166 (85.1) 150 (76.9) 156 (80.0)  
Education level   ** * **   0.008
Non schooled 81 (27.8) 61 (75.3) 73 (90.1) 59 (72.8) 67 (82.7)  
Primary school 105 (36.1) 62 (59.0) 83 (79.0) 69 (65.7) 71 (67.6)  
Secondary school 84 (28.9) 72 (85.7) 77 (91.7) 71 (84.5) 73 (86.9)  
High levelschool 21 (7.2) 17 (81.0) 17 (81.0) 19 (90.5) 17 (81.0)  
Religion       0.287
None or traditional 15 (5.2) 11 (73.3) 13 (86.7) 11 (73.3) 11 (73.3)  
Islam 149 (51.2) 103 (69.1) 126 (84.6) 108 (72.5) 112 (75.2)  
Christian 127 (43.6) 98 (77.2) 111 (87.4) 99 (78.0) 105 (82.7)  
Place of residence   * ° °   0.131
Urban 194 (66.7) 133 (68.6) 165 (85.1) 145 (74.7) 147 (75.8)  
Rural 97 (33.3) 79 (81.4) 85 (87.6) 17 (75.3) 81 (83.5)  
Alcohol consumption   ** * °  0.001
No 223 (76.6) 173 (77.6) 197 (88.3) 173 (77.6) 187 (83.9)  
Yes 68 (23.4) 39 (57.4) 53 (77.9) 45 (66.2) 41 (60.3)  
Clinical WHO stage   ° ° °   0.242
Stage I 53 (18.2) 39 (73.6) 45 (84.5) 39 (73.6) 41 (77.4)  
Stage II 132 (45.4) 95 (72.0) 113 (85.6) 101 (76.5) 109 (82.6)  
Stage III and IV 106 (36.4) 78 (73.6) 92 (86.8) 78 (73.6) 78 (73.6)  
Duration of ART therapy   ° * °   0.379
Less than one year 33 (11.3) 28 (84.8) 32 (97.0) 26 (78.8) 28 (84.8)  
1 to3 years 126 (43.3) 94 (74.6) 113 (89.7) 95 (75.4) 101 (80.2)  
More than 3years 132 (45.4) 90 (68.2) 105 (79.5) 97 (73.5) 99 (75.0)  
CD4’s count (last check-up)   * * °   0.022
CD4 ≤ 350 116 (39.9) 76 (65.5) 93 (80.2) 83 (71.6) 83 (71.6)  
CD4 > 350 175 (60.1) 136 (77.7) 157 (89.7) 135 (77.1) 145 (82.9)  
Therapeutic’s line   ° ° °   0.574
1 st line 274 (94.2) 200 (73.0) 236 (86.1) 204 (74.5) 216 (78.8)  
2 nd line 12 (4.1) 9 (75.0) 11 (91.7) 9 (75.0) 9 (75.0)  
3rd line 5 (1.7) 3 (60.0) 3 (60.0) 5 (100.0) 3 (60.0)  
Type of ART prescribed   ° ° °   0.310
Triomune 3 (1.0) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0)  
Duovir/EFV 36 (12.4) 22 (61.1) 31 (86.1) 25 (69.4) 27 (75.0)  
Duovir/NVP 243 (83.5) 181 (74.5) 210 (86.4) 182 (74.9) 192 (79.0)  
TNF/3TC/Aluvia 7 (2.4) 4 (57.1) 4 (57.1) 6 (85.7) 4 (57.1)  
ABC/DDI/Aluvia 2 (0.7) 2 (100.0) 2 (100.0) 2 (100.0) 2 (100.0)  
Reported side effects   ° ° °   0.988
No 240 (82.5) 175 (72.9) 210 (87.5) 178 (74.2) 188 (78.3)  
Yes 51 (17.5) 37 (72.5) 40 (78.4) 40 (78.4) 40 (78.4)  
ART perception by patient   ** ** **  0.001
Low 33 (11.3) 15 (45.5) 21 (63.6) 15 (45.5) 15 (45.5)  
Good 258 (88.7) 197 (76.4) 229 (88.8) 203 (78.7) 213 (82.6)  
HIV-status disclosure to sexual partner   ** ** **  0.001
No 84 (39.1) 39 (46.4) 62 (73.8) 48 (57.1) 46 (54.8)  
Yes 131 (60.9) 106 (80.9) 119 (90.8) 109 (83.2) 113 (86.3)  
Knowledge of the HIV sero-status of the sexual partner   ** * **  0.001
No 85 (39.5) 43 (50.6) 65 (76.5) 49 (57.6) 51 (60.0)  
Yes 130 (60.5) 102 (78.5) 116 (89.2) 108 (83.1) 108 (83.1)  
Self-report adherence to ART       
No 79 (27.1)      
Yes 212 (72.9)      
Appointment’s adherence to ART       
No 41 (14.1)      
Yes 250 (85.9)      
Pills count’s adherence to ART       
No 73 (25.1)      
Yes 218 (74.9)      
Global adherence to ART       
No 63 (21.6)      
Yes 228 (78.4)      
  1. ° : p > 0.05; * : p < 0.05; ** : p < 0.001.